Hasashen Kasuwar Magani na Radioimmunotherapy tare da Tasiri mai yuwuwar & Matsakaicin Gaba, Ya Nemo FMI 2022 - 2027

1648713427 FMI 15 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Cutar sankara ce kan gaba wajen mace-mace a duniya kuma ana hasashen zai karu da kimanin mutane miliyan 11.5 a shekarar 2030. Cutar da ta fi kamari ita ce ta huhu, wanda ya kai kimanin mutane miliyan 1.59, wasu nau'in ciwon daji sun hada da ciwon hanta, ciwon nono, ciwon ciki, ciwon hanta, da dai sauransu. Ana iya magance ciwon daji ta hanyar tiyata, chemotherapy, radiation far, hormone far, maganin da aka yi niyya, daidaitaccen magani, immunotherapy da kuma dashen kwayoyin halitta. Immunotherapy ya ƙunshi amfani da tsarin garkuwar jikin mutum don yaƙar ciwon daji; ya haɗa da ƙarfafa tsarin rigakafi don kai hari ga ƙwayoyin cutar kansa ko samar da tsarin rigakafi da tsarin rigakafi na mutum.

Daban-daban na immunotherapy sun haɗa da ƙwayoyin rigakafi na monoclonal, wanda aka tsara don kai hari ga takamaiman sel; masu hana shingen kariya na rigakafi, magungunan da ke ganewa da kai hari ga ƙwayoyin kansa ta hanyar cire birki na kwayar T; allurar rigakafin ciwon daji, waɗanda ake amfani da su don haifar da martani na rigakafi akan takamaiman cuta da sauran nau'ikan rigakafi daban-daban waɗanda ba takamaiman takamaiman ba ana amfani da su don haɓaka tsarin rigakafi. Radioimmunotherapy shine haɗin maganin radiation da immunotherapy. Monoclonal antibody an ƙera shi a cikin dakin gwaje-gwaje kuma an haɗa shi da kayan aikin rediyo da ake kira radiotracers. Lokacin da aka yi masa allura, rediyon ya yi wa lakabin antibody don ɗaure takamaiman kwayar cutar kansa kuma ya lalata kwayar cutar kansa ta hanyar aikin rediyo. Abubuwan da ake amfani da su na rediyoaktif galibi sune Yttrium-90 Ibritumomab Tiuxetan, Iodine-131 Tositumomab, da sauransu.

Don ci gaba da 'gaba da' fafatawa a gasa, nemi a kasida: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3701

Gwaje-gwaje na asibiti da yawa suna ci gaba don tabbatar da yuwuwar rediyo mai lakabin ƙwayar cuta ta monoclonal. Hakanan ana amfani da radioimmunotherapy don kula da marasa lafiya da ke fama da cutar sankarau waɗanda ba Hodgkin B-cell lymphoma, da sauran nau'ikan nau'ikan lymphoma ko marasa lafiya waɗanda ba sa amsa chemotherapy. Gabaɗaya, ba a ganin illa a lokacin jiyya. A cikin filin asibiti, ana yin karatun asibiti don haɓaka ingantaccen ilimin halitta da sinadarai da haɓaka hanyoyin jiyya a cikin radioimmunotherapy. Ana amfani da hanyoyin kai tsaye da kaikaice wajen isar da kwayoyin halittar rediyoimmunotherapy. Haɓaka kudade na hankali don binciken cutar kansa daga hukumomin gwamnati da na tarayya, haɓaka ɗaukar hoto na Medicare, haɓakar cutar kansa a tsakanin karuwar yawan jama'a, samun sabon maganin cutar kansa, da sauran abubuwa daban-daban za su mamaye kasuwar radioimmunotherapy nan gaba.

Kasuwar Magani na Radioimmunotherapy: Direbobi da Kamewa

A cewar Word Health Organisation, an kiyasta cewa nan da shekarar 2030, kimanin sabbin masu kamuwa da cutar kansa miliyan 23.6 za su yi galaba a duniya. Jagororin gwamnati daga al'ummar ilimin kimiyya na Amurka da kuma cikakken Cibiyar Canjin Kasa (NCCN / ASCO) suna ba da taimako ga kwararrun kiwon lafiya da kuma lura da masu cutar daji da cutar ciwon daji. Bincike mai zurfi da ci gaba a cikin magungunan ciwon daji, haɓakar abubuwan da ke faruwa na ciwon daji, ya karu da fifiko ga binciken ciwon daji. A cikin Afrilu 2016, Gwamnatin Amurka ta ware dalar Amurka biliyan 5.2 ga Cibiyar Ciwon daji ta Kasa (NCI), wata hukumar gwamnatin tarayya, don bincike da horar da cutar kansa. Kasafin kudin ya karu da kashi 5.3% idan aka kwatanta da shekarar da ta gabata. Inshorar inshora da al'amurran da za a biya, manyan kamfanoni suna zuba jari mai yawa a cikin magungunan ciwon daji da suka shafi lokaci da kudi, kuma babu tabbacin cewa samfurin zai sami ɗaukar hoto, hadarin radiation ga masu sana'a na kiwon lafiya da marasa lafiya wasu dalilai ne da zasu iya hana ci gaban rediyo. - kasuwar rigakafi

Kasuwar Magani na Radioimmunotherapy: Bayani

Dangane da nau'in miyagun ƙwayoyi, na duniya kasuwar jiyya na radioimmunotherapy An kasu kashi zuwa ibritumomab, tositumomab, rituximab, epratuzumab, lintuzumab, labetuzumab da trastuzumab. Dangane da nau'in tsari, kasuwar jiyya ta radioimmunotherapy ta kasu kashi cikin hanya kai tsaye da kai tsaye. O Dangane da alamun cutar, kasuwa ta kasu kashi cikin lymphoma marasa hodgkin, cutar sankarar jini myeloid, kansar launi, kansar nono, myeloma da yawa da sauransu. Dangane da mai amfani da ƙarshen, kasuwar ta kasu kashi cikin asibiti, cibiyoyin tiyata na asibiti da cibiyoyin binciken kansa. Haɓaka yawan masu fama da cutar kansa, tallafi daga hukumomin gwamnati, mai da hankali kan siye da haɗin gwiwa ta manyan masana'antun masana'antu daban-daban ana danganta su zuwa haɓakar kasuwar jiyya ta rediyo-immunotherapy.

Kasuwar Magani na Radioimmunotherapy: Bayanin Yanki

Yanki mai hikima, Kasuwancin Maganin Radiyo na Duniya an rarraba shi cikin yankuna, Arewacin Amurka, Latin Amurka, Yammacin Turai, Gabashin Turai, Asiya-Pacific, Japan, Gabas ta Tsakiya da Afirka. Fiye da kashi 70 cikin 33 na masu fama da cutar daji a duniya suna faruwa a Afirka, Asiya da Kudancin Amurka. Kusan kashi XNUMX cikin XNUMX na masu kamuwa da cutar daji a duniya suna haifar da hayaki da taba. Tare da fadadawa a cikin kasuwanni masu tasowa, da kuma mai da hankali kan ganewar asali da wuri, dubawa, kulawa da ci gaban asibiti da ke hade da maganin rediyo sun kasance manyan dabarun da manyan 'yan wasa suka dauka a kasuwar maganin radioimmunotherapy na duniya.

Kasuwar Magani na Radioimmunotherapy: Maɓallai ƴan wasa

Wasu daga cikin manyan 'yan wasa a cikin Kasuwancin Jiyya na Radioimmunotherapy na duniya sune GlaxoSmithKline plc. Bayer AG, MabVax Therapeutics Holdings, Inc., Panacea Pharmaceuticals, Inc. Nordic Nanovector, Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Spectrum Pharmaceuticals, Inc. da sauransu.

Rahoton bincike yana gabatar da cikakken ƙimar kasuwa kuma ya ƙunshi tunani mai zurfi, gaskiya, bayanan tarihi, da tallafi na ƙididdiga tare da ingantaccen kasuwancin masana'antu. Hakanan ya ƙunshi tsinkaye ta amfani da saitaccen zato da kuma hanyoyin aiki. Rahoton binciken yana ba da bincike da bayani gwargwadon rukuni kamar bangarorin kasuwa, yanki, nau'ikan samfura da aikace-aikace.

Rahoton ya ba da cikakken bincike game da:

  • Yankunan Kasuwa
  • Tasirin Kasuwa
  • Girma Kasuwa
  • Bayarwa & Buƙata
  • Nauyi Na Zamani / Al'amuran / Kalubale
  • Gasar & Kamfanoni da ke ciki
  • Technology
  • Sarkar Taya

Binciken yanki ya haɗa da

  • Arewacin Amurka (Amurka, Kanada)
  • Latin Amurka (Mexico, Brazil da sauran Latin Amurka)
  • Yammacin Turai (Jamus, Italiya, Faransa, UK, Spain, ƙasashen Nordic, Belgium, Netherlands, Luxembourg da sauran Yammacin Turai)
  • Gabashin Turai (Poland, Rasha da sauran Gabashin Turai)
  • Asia Pacific (China, India, ASEAN, Australia da New Zealand)
  • Japan
  • Gabas ta Tsakiya da Afirka (GCC, S. Africa, da sauran MEA)

Rahoton shine tarin bayanai na farko, ƙima da ƙima na masana'antu na masana'antu, bayanai daga masana masana'antu da mahalarta masana'antu a cikin sarkar darajar. Rahoton ya ba da zurfin bincike game da yanayin kasuwancin iyaye, alamomin tattalin arziki da kuma abubuwan gudanarwa tare da sha'awar kasuwa kamar kowane bangare. Rahoton ya kuma yi taswirar ingancin tasirin abubuwan kasuwa daban-daban akan sassan kasuwa da yanki

Kasuwar Magani na Radioimmunotherapy: Rarraba

An rarraba kasuwar jiyya ta rediyoimmunotherapy ta duniya bisa nau'in magani, nau'in tsari, alamun cuta, nau'in manufa da yanayin ƙasa.

Dangane da Nau'in Magunguna, kasuwar jiyya ta radioimmunotherapy ta kasu kashi masu zuwa:

  • Ibritumab
  • Tositumomab
  • Rituximab
  • Epratuzumab
  • Lintuzumab
  • Labetuzumab
  • Trastuzumab
  • wasu

Dangane da Nau'in Tsari, kasuwar jiyya ta radioimmunotherapy ta duniya ta kasu zuwa masu zuwa:

  • Hanyar Kai tsaye
  • Hanyar kai tsaye

Dangane da Alamar Cutar, kasuwar jiyya ta radioimmunotherapy ta duniya ta kasu zuwa masu zuwa:

  • Lymphoma ba Hodgkin
  • Myeloid cutar sankarar bargo
  • Colorectal ciwon daji
  • nono
  • Multiye Myeloma
  • wasu

Dangane da Mai amfani na Ƙarshen, kasuwar jiyya ta radioimmunotherapy ta duniya ta kasu zuwa masu zuwa:

  • asibitoci
  • Cibiyoyin tiyata na gaggawa
  • Cibiyoyin Binciken Ciwon daji
  • wasu

Don zama mataki ɗaya gaba, sami TOC na wannan Rahoton:  https://www.futuremarketinsights.com/toc/rep-gb-3701

Rahotanni na Ƙididdiga:

  • Cikakken bayani game da kasuwar iyaye
  • Canza kuzarin kasuwa a masana'antar
  • A cikin zurfin yanki kashi
  • Adabin tarihi, na zamani da na hango girman kasuwa dangane da girma da darajar
  • Sabbin masana'antu da ci gaban zamani
  • Ƙasa mai faɗi
  • Dabarun manyan 'yan wasa da kayayyakin da aka bayar
  • M yankuna masu kusurwa, yankuna yanki suna nuna haɓaka mai kyau
  • Matsayi tsaka tsaki kan aikin kasuwa
  • Dole ne a sami bayanai don 'yan wasan kasuwar su ci gaba da bunkasa ƙafafun kasuwancin su

Game da Bayanin Kasuwanci na Gaba (FMI)
Hasashen Kasuwa na gaba (FMI) shine babban mai ba da bayanan sirri na kasuwa da sabis na tuntuɓar, yana yiwa abokan ciniki hidima a cikin ƙasashe sama da 150. FMI tana da hedikwata a Dubai, kuma tana da cibiyoyin bayarwa a Burtaniya, Amurka da Indiya. Sabbin rahotannin bincike na kasuwa na FMI da nazarin masana'antu suna taimaka wa 'yan kasuwa su gudanar da ƙalubale da yanke shawara mai mahimmanci tare da tabbaci da tsabta a tsakanin gasa ta karya wuya. Rahoton bincike na kasuwa na musamman da haɗin kai yana ba da fa'idodi masu dacewa waɗanda ke haifar da ci gaba mai dorewa. Tawagar ƙwararrun manazarta a FMI suna ci gaba da bin diddigin abubuwan da suka kunno kai da abubuwan da suka faru a cikin masana'antu da yawa don tabbatar da cewa abokan cinikinmu sun shirya don buƙatun masu amfani da su.

Saduwa da Mu:
Fadakarwar Kasuwa ta gaba
Naúrar No: AU-01-H Hasumiyar Zinare (AU), Ƙirar Ƙimar: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Don Tambayoyin Ciniki: [email kariya]
Don Tambayoyin Media: [email kariya]
Yanar Gizo: https://www.futuremarketinsights.com

Hanyoyin tushen

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...